Clinical trial / 2002
Genistein supplementation improved bone mineral density and bone turnover markers in postmenopausal women.
A randomized controlled trial assigned 90 healthy postmenopausal women to receive hormone replacement therapy, 54 mg/day of genistein, or placebo for one year. At 12 months, genistein increased femoral neck bone mineral density by 3.6 +/- 3% and lumbar spine density by 3 +/- 2% (P < 0.001 compared to placebo). Genistein also decreased urinary pyridinium cross-links and increased bone-specific alkaline phosphatase and osteocalcin.
- Study type
- Randomized controlled trial
- Who was studied
- 90 postmenopausal women aged 47-57
- What was measured
- Bone mineral density and markers of bone turnover
THE PAPER
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F. J Bone Miner Res, 2002.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.